Comorbidities and confusion: addressing COVID-19 vaccine access and information challenges

Early in the coronavirus disease 2019 (COVID-19) pandemic, evidence emerged that individuals with chronic and immunocompromising conditions faced increased risk of severe infection, including death. The Australian Government and public health authorities prioritised these citizens' access to vaccines, including them in phase 1b of the rollout from 22 March 2021.

Citation:
Attwell K, Roberts L, Blyth CC. Comorbidities and confusion: addressing COVID-19 vaccine access and information challenges. Commun Dis Intell (2018). 2024;48.

Keywords:
COVID-19; chronic disease management; communication and marketing; epidemic; health policy

Abstract:
Early in the coronavirus disease 2019 (COVID-19) pandemic, evidence emerged that individuals with chronic and immunocompromising conditions faced increased risk of severe infection, including death. The Australian Government and public health authorities prioritised these citizens' access to vaccines, including them in phase 1b of the rollout from 22 March 2021.